Several small pharma units told to halt operations over quality

The Central Drugs Standard Control Organisation (CDSCO) has been conducting risk-based inspections of drug manufacturing units as part of a nationwide crackdown on spurious and substandard drugs. Several units in Baddi, Himachal Pradesh, and Punjab have been inspected, with show-cause notices issued and production stopped at some.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/08DB76h
via IFTTT